Site of entry and surgical timing in infective endocarditis

J Cardiovasc Med (Hagerstown). 2018 Feb:19 Suppl 1:e16-e18. doi: 10.2459/JCM.0000000000000561.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cardiac Surgical Procedures* / adverse effects
  • Cardiac Surgical Procedures* / mortality
  • Clinical Decision-Making
  • Endocarditis / diagnosis
  • Endocarditis / microbiology
  • Endocarditis / mortality
  • Endocarditis / surgery*
  • Gastrointestinal Microbiome
  • Humans
  • Mouth / microbiology
  • Recurrence
  • Risk Assessment
  • Risk Factors
  • Skin / microbiology
  • Time Factors
  • Time-to-Treatment*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents